Dhanuka Agritech

Basis of our Recommendation

Dhanuka Agritech's recent management commentary highlights a cautious outlook for FY 2027, primarily due to cyclical headwinds from delayed monsoon onset and pricing pressures that have impacted Q1 performance, resulting in a 12.56% revenue decline. Despite these challenges, the company is strategically investing in a new formulation plant in Nagpur and expanding its international footprint through the acquisition of Bayer's fungicide portfolio, which positions it for long-term growth. Vista's financial outlook reflects stable revenue growth aligned with historical performance, although margins are expected to face pressure due to fixed cost rigidities and weak herbicide demand. The improving pricing power in the fertilizers and pesticides sector, driven by rising chemical prices, supports Dhanuka's strategic initiatives. However, the company must navigate risks such as climate volatility and execution challenges in international markets. Over the next 12-24 months, key opportunities include the successful launch of new products and the scaling of its biologicals portfolio, while watchpoints include the impact of geopolitical tensions on input costs and the operational performance of the Dahej facility